Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris

Journal of the American Academy of Dermatology

Volumn 44, Issue 2, 2001, Pages 198-206

  Schaffer, Julie V ^a   Davidson, Diane M ^a   McNiff, Jennifer M ^a   Bolognia, Jean L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; MINOCYCLINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ACNE VULGARIS; ADULT; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CASE REPORT; DERMIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEG; LIVEDO RETICULARIS; LONG TERM CARE; LUPUS ERYTHEMATOSUS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; SUBCUTANEOUS NODULE;

EID: 0035110648     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.112218     Document Type: Article

References (90)

1. Distressing side-effects of minocycline hydrochloride
2. Cutaneous pigmentation due to minocycline hydrochloride
3. Ultrastructural and x-ray microanalytical observations of minocycline-related hyperpigmentation of the skin
4. Extensive cutaneous hyperpigmentation caused by minocycline
5. Pulmonary infiltrates with eosinophilia associated with tetracycline
6. Acute hepatitis and exfoliative dermatitis associated with minocycline
7. Protracted systemic illness and interstitial nephritis due to minocycline
8. Minocycline-induced cell-mediated hypersensitivity pneumonitis
9. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne
10. Minocycline pneumonitis and eosinophilia: A report on eight patients
11. Minocycline as possible cause of severe and protracted hypersensitivity drug reaction
12. Minocycline and pulmonary eosinophilia
13. Serious adverse reactions induced by minocycline: Report of 13 cases and review of the literature
14. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: A severe adverse reaction to minocycline
15. Minocycline hypersensitivity with respiratory failure
16. Serum-sickness-like syndrome associated with minocycline therapy
17. Serum-sickness-like reaction associated with minocycline therapy in adolescents
18. Minocycline-induced serum sickness
19. Comparative safety of tetracycline, minocycline, and doxycycline
20. Minocycline-related lupus
21. Minocycline-related lupus
22. Minocycline related lupus in childhood
23. Lupus-like syndrome associated with the use of minocycline
24. Minocycline-related lupus
25. Lupus-like syndrome in patients treated for acne
26. Minocycline-associated lupus erythematosus
27. Minocycline-induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome
28. Lupus-like syndrome following minocycline consumption
29. Minocycline-induced liver injury
30. Minocycline-related lupus
31. Minocycline-related lupus erythematosus with associated liver disease
32. Minocycline-induced lupus
33. Acute hepatitis and drug related lupus induced by minocycline treatment
34. Study of immune reactivity of minocycline-induced chronic active hepatitis
35. Minocycline-related lupus
36. Minocycline-induced lupus in adolescents
37. Clinical and immunologic study of 7 patients with minocycline-induced autoimmune phenomena
38. Minocycline-induced arthritis
39. Arthralgias, myalgias, and autoimmune hepatitis with minocycline therapy
40. Minocycline-related autoimmune hepatitis
41. Minocycline-induced lupus and autoimmune hepatitis
42. Respiratory distress due to minocycline-induced pulmonary lupus
43. Minocycline-induced clinical and biological lupus-like disease
44. Highly positive dsDNA antibodies in minocycline-induced lupus
45. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome
46. Minocycline-induced hepatitis with autoimmune features and neutropenia
47. Complications of minocycline therapy for acne vulgaris: Case reports and review of the literature
48. Minocycline and lupus-like syndrome in acne patients
49. Minocycline-induced arthritis associated with fever, livedo reticularis, and pANCA
50. Drug-related lupus
51. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies
52. Evolving concepts about the role of antineutrophil cytoplasm autoantibodies in systemic vasculitides
53. Antineutrophil cytoplasmic antibodies
54. Cutaneous polyarteritis nodosa in a child with positive antiphospholipid and P-ANCA
55. Drugs associated with vasculitis
56. Autoantibodies against neutrophil cytoplasm components in SLE and in hydralazine-induced lupus
57. Antineutrophil cytoplasmic autoantibodies (ANCA) recognizing a recombinant myeloperoxidase subunit
58. Systemic vasculitis resembling periarteritis nodosa in the lupus-like syndrome induced by hydralazine
59. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis
60. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis
61. Propylthiouracil induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies
62. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy
63. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment
64. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA): Review of the literature
65. Crescentic glomerulonephritis in a patient taking penicillamine associated with antineutrophil cytoplasmic antibody
66. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis
67. Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy
68. Hydrallazine-induced cutaneous vasculitis
69. Propylthiouracil-induced cutaneous vasculitis: Case presentation and review of the literature
70. Hydrallazine-induced necrotising vasculitis
71. Hydralazine-induced necrotising vasculitis
72. Nodular vasculitis associated with propylthiouracil therapy
73. Necrotizing vasculitis in association with D-penicillamine therapy: Report of a case
74. Minocycline-induced autoimmune syndromes: An overview
75. Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis
76. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils
77. Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris
78. Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris
79. Cutaneous polyarteritis nodosa
80. Cutaneous periarteritis nodosa
81. Cutaneous periarteritis nodosa: A clinicopathological study of 79 cases
82. Cutaneous polyarteritis nodosa in a child
83. Cutaneous polyarteritis nodosa
84. Benign cutaneous polyarteritis nodosa: Relationship to systemic polyarteritis nodosa and to hepatitis B infection
85. Cutaneous polyarteritis nodosa in a young child
86. Nomenclature of systemic vasculitides: Proposal of an international consensus conference
87. Systemic vasculitis with coexistent large and small vessel involvement: A classification dilemma
88. Nomenclature and classification of vasculitis: Plus ça change, plus c'est la me̊me chose
89. Vascular diseases
90. Hyperpigmentation, neutrophilic alveolitis, and erythema nodosum resulting from minocycline